As of 2025-10-18, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 43.38 mil USD. MRNS's TTM EBITDA according to its financial statements is -121.83 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 14.9x | 13.0x |
| Forward P/E multiples | 12.4x - 24.1x | 19.4x |
| Fair Price | (27.50) - (33.15) | (35.92) |
| Upside | -5100.8% - -6127.7% | -6631.1% |
| Date | EV/EBITDA |